|
|
Liangyou Rui
J Clin Invest. 2007;
117(2):310
doi:10.1172/JCI31289
Abstract |
Full text
| PDF
N
utrient overload induces obesity, a primary risk factor for type 2 diabetes. Ribosomal biogenesis and protein synthesis, which are controlled by the mammalian target of rapamycin (mTOR), are primary energy-consuming processes in cells. mTOR phosphorylates and inactivates members of the eukaryotic translation initiation factor 4E–binding (eIF4E-binding) protein (4E-BP) family, which are translational repressors of 5′ cap–dependent protein synthesis. In this issue of the JCI, Le Bacquer et al. report that simultaneous deletion of both 4E-BP1 and 4E-BP2 in mice results in insulin resistance, decreased energy expenditure, and increased adipogenesis (see the related article beginning on page 387). These findings link protein synthesis, insulin sensitivity, and body weight.
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal.
Not all publishers participate in CrossRef, so this information is not comprehensive.
Additionally, data may not reflect the most current citations to this article,
and the data may differ from citation information available from other sources
(for example, Google Scholar, Web of Science, and Scopus).
Total citations by year
in CrossRef
Citations to this article
in CrossRef
(6)
| Title and authors |
Publication |
Year |
Positive regulation of inositol 1,4,5-trisphosphate-induced ca2+ release by mammalian target of rapamycin (mTOR) in RINm5F cells
Marc-Olivier Frégeau, Yannik Régimbald-Dumas, Gaétan Guillemette
|
J. Cell. Biochem.
|
2011 |
Effects of rapamycin and TOR on aging and memory: implications for Alzheimer’s disease
Renato X. Santos, Sónia C. Correia, Susana Cardoso, Cristina Carvalho, Maria S. Santos, Paula I. Moreira
|
Journal of Neurochemistry
|
2011 |
Metabolic syndrome as a risk factor for neurological disorders
Akhlaq A. Farooqui, Tahira Farooqui, Francesco Panza, Vincenza Frisardi
|
Cell. Mol. Life Sci.
|
2011 |
Clinical Outcomes in Kidney Transplant Recipients Receiving Long-Term Therapy With Inhibitors of the Mammalian Target of Rapamycin : mTOR Inhibitors and Outcomes
M. Z. Molnar, T. Isakova, M. E. Czira, C. P. Kovesdy, D. Roth, I. Mucsi, M. Wolf, F. Cortazar
|
Am J Transplant
|
2011 |
The combination of sirolimus and rosiglitazone produces a renoprotective effect on diabetic kidney disease in rats
Maria Flaquer, Núria Lloberas, Marcella Franquesa, Joan Torras, August Vidal, Jose Luis Rosa, Immaculada Herrero-Fresneda, Josep M Grinyó, Josep M Cruzado
|
Life Sciences
|
2010 |
Adipose stress-sensing kinases: linking obesity to malfunction
Assaf Rudich, Hannah Kanety, Nava Bashan
|
Trends in Endocrinology & Metabolism
|
2007 |
|